2-(5-Ethylpyridin-2-yl)ethyl methanesulfonate

Catalog No. :
ACLJQK241
CAS No. :
144809-26-7
Molecular Formula :
C10H15NO3S
Molecular Weight :
229.30

IUPAC Name:2-(5-ethylpyridin-2-yl)ethyl methanesulfonate

2-(5-Ethylpyridin-2-yl)ethyl methanesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-Ethylpyridin-2-yl)ethyl methanesulfonate
IUPAC Name2-(5-ethylpyridin-2-yl)ethyl methanesulfonate
Molecular FormulaC10H15NO3S
Molecular Weight229.30
SMILESO=S(OCCC1=NC=C(CC)C=C1)(C)=O
InChI KeyQBBOABZXKOJOEC-UHFFFAOYSA-N
SynonymPioglitazone Process impurity 2;2-Pyridineethanol, 5-ethyl-, 2-methanesulfonate;2-(5-ethylpyridin-2-yl)ethyl methanesulfonateQ: What is 2-(5-ethylpyridin-2-yl)ethyl methanesulfonate Q: What is the CAS Number of 2-(5-ethylpyridin-2-yl)ethyl methanesulfonate;2-(5-Ethylpyridin-2-yl)ethyl Methanesulfonate;METHYL SULPHOTE PGS;Pioglitazone hydrochloride Impurity 46;Belumosudil Impurity42
CAS No.144809-26-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLJQK241 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCBML602 route compound structure diagram
    ACCBML6025223-06-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLJQK241 route product structure diagram
    ACLJQK241144809-26-7
Inquiry

2. ACLJQK241 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCBML602 route compound structure diagram
    ACCBML6025223-06-3 In Stock
  2. Then
  3. ACLJQK241 route product structure diagram
    ACLJQK241144809-26-7
Inquiry

Comments (0)